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be oflittle help to the reader interested in learning more about a particular aspect of
the disease.
In spite of these shortcomings, however, this book could be of use to the patient
with multiple sclerosis. Practical advice for coping with everyday problems and
frank discussion of "touchy" subjects could be invaluable to the patient who feels
overwhelmed by the disease.
CATHARINE ARNOLD
Medical Student
Yale University School ofMedicine
CEREBROVASCULAR DISEASES. THIRTEENTH RESEARCH (PRINCETON) CONFERENCE.
Edited by Martin Reivich and Howard I. Hurtig. New York, Raven Press, 1983.
437 pp. $73.00.
This book is a compilation of papers presented at the Thirteenth Research Con-
ference on Cerebrovascular Disease held at Williamsburg, Virginia, from February
28 to March 2, 1982. It was sponsored by the American Neurological Association
and the American Heart Association, Stroke Council. An international panel of
participants from North America and Europe composed of research scientists and
clinicians-neurologists, neurosurgeons, pathologists, pharmacologists, epidemiol-
ogists, and others-took part in the conference.
Both basic research and clinical papers are presented. The initial portion of the
book contains a brief overview of the mechanism of NMR, as well as present and
potential uses of NMR and PET scanning in cerebrovascular disease. Both modali-
ties represent potential quantum leaps in research and clinical management ofstroke
patients. PET scanning appears to be the current test of choice for evaluation of
cerebral tissue blood flow and metabolism. Abstracts ofsome ofthe discussions that
followed the presentations are presented throughout the book and are, in general,
quite pertinent. For example, the discussion concerning the potential dangers of
metallic objects-notably ferromagnetic-on or in the body of a patient undergoing
an NMR scan is of interest and clinically significant.
The second major section of this book deals with prognostic indicators in cere-
brovascular disease. Many of these articles contain important clinical implications.
Some of the more notable presentations merit brief mention. The significant de-
crease in stroke mortality, especially over the past 15 years, is felt to be a direct result
ofimproved therapy ofheart disease and hypertension. A most interesting article by
Norris and D'Alton concludes that current published data on surgical versus con-
servative management of the asymptomatic carotid bruit is inadequate to decide on
correct therapeutic management. Age, hypertension, heart disease, and diabetes are
noted as the most important risk factors in both transient ischemic attacks (TIAs)
and stroke. Another presentation notesthat there is no clear-cut evidence asto which
ofvarious treatment modalities is superior for acute cerebral infarction in evolution.
Four factors which were seen as clinical predictors ofstroke severity in a prospective
study at the New York Hospital were: (1) degree of focal neurological deficit, (2)
level of sensorium, (3) decrease in brain density on CT scan, and (4) blood sugar
level on hospital admission. Location and type of stroke also correlate with the se-
verity of residual deficits, and post-stroke affective disorders are common, espe-
cially depression. A comparative review of the results of therapy for subarachnoid256 BOOK REVIEWS
hemorrhage from 1963 to 1977 suggests that the prognosis for such hospitalized pa-
tients has significantly improved.
The third and largest portion of this text deals with critical factors in prevention
of irreversible ischemic damage. A number of predominantly experimental papers
are presented. Electron micrographs depict the expansion and rupture of cerebral
capillaries in areas of infarction and reperfusion. Several factors may influence the
degree ofdamage from cerebral ischemia. These include lactic acid and/or hydrogen
ions, calcium metabolism, abnormal polyunsaturated fat metabolism, initial degree
of hyperglycemia, and leukotrienes. The partially ischemic brain around an area of
frank necrosis is an area in which future therapy may be stressed. PET scanning
could be a major aid in planning therapy. Ackerman noted that some PET scans
have shown that delayed cerebral metabolic effects of subarachnoid hemorrhage
may be seen to be increased up to a year after the initial bleed.
The final portion of the text is concerned with intravascular factors in cerebro-
vascular disease. It comprises mainly experimental papers on topics including the
role of fibrinogen in cerebral blood flow, improved scintigraphic detection of intra-
vascular thrombi, arterial wall changes in experimental stenosis, and a new anti-
thrombotic drug. In a more clinical vein, a report noted that low-dose subcutaneous
heparin did not prevent stroke progression. A particularly interesting paper con-
cerned Auer's use of nimodipine (a calcium antagonist used in the treatment of
coronary insufficiency). Administration of nimodipine in cases with subarachnoid
hemorrhage caused significant vascular dilatation via either intravascular or topical
administration. This may represent a major new therapeutic approach in preventing
cerebral ischemia secondary to the vasospasm of subarachnoid hemorrhage.
Overall, this is a good review of current "state-of-the-art" research and clinical
forefronts concerning cerebrovascular disease. The text is not recommended for
medical students, or residents in medical fields dealing with cerebrovascular disease.
Basic texts and pertinent journals are more appropriate at these academic levels.
However, this book is recommended reading for attending clinicians and/or re-
searchers who deal with cerebrovascular disease.
IsAAc GOODRICH
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Nearly every malignancy capable of distant spread can metastasize to bone, but
the detection and management of such metastases has not been clearly elucidated.
Radiologic methods of detection such as technetium scanning and conventional
radiographs have been proven by autopsy series to be quite insensitive. Processes as
basic to malignancy as local tissue response to tumor, destruction of host tissues by
tumor, and the development of hypercalcemia are all clinically monitored to follow
the progress of bone metastases, but remain poorly understood. The pharmacology
ofanti-osteolytic agents isjust now starting to affect patient care, but bone pain and
pathologic fractures continue to be among the most disabling aspects of cancer. The